Oruka Therapeutics, Inc. (ORKA) Free cash flow 2016–2025
Oruka Therapeutics, Inc. (ORKA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$88.4MFY2025 · since FY2016: -$15.0M → -$88.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$88.4M | — |
| FY2023 | -$5.0M | +54.1% |
| FY2022 | -$10.9M | +42.0% |
| FY2021 | -$18.8M | -142.8% |
| FY2020 | -$7.7M | -61.2% |
| FY2019 | -$4.8M | +41.7% |
| FY2018 | -$8.2M | +52.8% |
| FY2017 | -$17.5M | -16.5% |
| FY2016 | -$15.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ORKA financial trends
ORKA RevenueORKA Net incomeORKA Net marginORKA Gross profitORKA Gross marginORKA Operating incomeORKA Operating marginORKA Operating cash flowORKA Capital expendituresORKA Return on equityORKA Stock buybacksORKA Dividends paidORKA Total assetsORKA Total liabilitiesORKA Shareholders’ equityORKA overview →